Finance

Lists
Why is RAD up 33.33%?
Dive Deeper
RAD:ASX
Radiopharm Theranostics Ltd
A$0.0040
+33.33%
(+0.0010) 1D
Nov 4, 4:00:00 PM GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RAD...
Open
A$0.00
High
A$0.00
Low
A$0.00
Mkt. cap
9.42M
Avg. vol.
6.88M
Volume
11.29M
52-wk high
A$0.04
52-wk low
A$0.00
EPS
-A$0.02
Shares outstanding
4.71B
No. of employees
14
Open
A$0.00
High
A$0.00
Low
A$0.00
Mkt. cap
9.42M
Avg. vol.
6.88M
Volume
11.29M
52-wk high
A$0.04
52-wk low
A$0.00
EPS
-A$0.02
Shares outstanding
4.71B
No. of employees
14
News stories
From web sources and news partners
About Radiopharm Theranostics Ltd
CEO-
Employees14
Founded2021
Headquarters-
SectorBiotechnology
Industry-
Websiteradiopharmtheranostics.com
Last report
Jan 30, 2025
Fiscal period
Q2 2025
-$0.01 / -$0.01
+9.57%beat
Revenue / Est. (USD)
859.04K / 0.00
+∞%beat
Fiscal Q2 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.10M
3.10M
3.33M
3.33M
Cost of goods sold
11.30M
11.30M
12.30M
12.30M
Cost of revenue
11.30M
11.30M
12.30M
12.30M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.18M
4.18M
3.92M
3.92M
Operating expense
4.95M
4.95M
4.36M
4.36M
Total operating expenses
16.25M
16.25M
16.67M
16.67M
Operating income
-13.14M
-13.14M
-13.33M
-13.33M
Other non operating income
-
-
-
-
EBT including unusual items
-14.05M
-14.05M
-14.39M
-14.39M
EBT excluding unusual items
-13.37M
-13.37M
-13.18M
-13.18M
Income tax expense
67.15K
67.15K
-39.93K
-39.93K
Effective tax rate
-0.48%
-0.48%
0.28%
0.28%
Other operating expenses
-
-
-
-
Net income
-13.48M
-13.48M
-14.99M
-14.99M
Net profit margin
-434.67%
-434.67%
-450.12%
-450.12%
Earnings per share
-
-
-
-
Interest and investment income
-
-
318.57K
318.57K
Interest expense
-32.55K
-32.55K
-23.64K
-23.64K
Net interest expenses
-32.55K
-32.55K
294.93K
294.93K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.47M
-12.47M
-12.66M
-12.66M
Gain or loss from assets sale
-
-
106.38K
106.38K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps